FDA authorizes first T cell-based test to detect prior SARS-CoV-2
Psychedelic science holds promise for mainstream medicine
10 March 2021Expert says origins of pandemic could be known in few years
10 March 2021FDA authorizes first T cell-based test to detect prior SARS-CoV-2
(HealthDay)—The T-Detect COVID Test, a T cell-based test that helps to identify individuals with recent or prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, was granted emergency use authorization, the U.S. Food and Drug Administration announced Friday.
